Sanofi settles EU antitrust probe, U.S. FTC seeks contempt from Shkreli
Sanofi agreed to settle an EU antitrust investigation into its campaign against a rival flu vaccine, avoiding a fine. Meanwhile, the U.S. Federal Trade Commission and seven states are seeking contempt from Martin Shkreli for violating a court order banning him from working in the pharmaceutical industry.
Why it matters. Pharmaceutical companies and executives face regulatory scrutiny and legal consequences for misleading practices and violations of industry bans.
